• Return to Headlines

Ligand Pharm Shares Up 21.5% Since SmarTrend's Buy Recommendation (LGND)

By Shiri Gupta

SmarTrend identified an Uptrend for Ligand Pharm (NASDAQ:LGND) on June 21st, 2018 at $199.56. In approximately 2 months, Ligand Pharm has returned 21.45% as of today's recent price of $242.36.

In the past 52 weeks, shares of Ligand Pharm have traded between a low of $121.22 and a high of $254.24 and are now at $242.36, which is 100% above that low price. The 200-day and 50-day moving averages have moved 1.13% higher and 1.88% higher over the past week, respectively.

Ligand Pharmaceuticals Incorporated develops drugs which regulate hormone activated intracellular receptors. These receptors play a role in regulating the genetic processes affecting diseases such as gynecological disorders and certain cancers, as well as cardiovascular, inflammatory, and skin diseases.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Ligand Pharm shares.

Log in and add Ligand Pharm (LGND) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights ligand pharm

Ticker(s): LGND